Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Visual signs and symptoms of Parkinson's disease.

Armstrong RA.

Clin Exp Optom. 2008 Mar;91(2):129-38. doi: 10.1111/j.1444-0938.2007.00211.x. Review.

2.

Oculo-Visual Dysfunction in Parkinson's Disease.

Armstrong RA.

J Parkinsons Dis. 2015;5(4):715-26. doi: 10.3233/JPD-150686. Review.

3.

Visual signs and symptoms of dementia with Lewy bodies.

Armstrong RA.

Clin Exp Optom. 2012 Nov;95(6):621-30. doi: 10.1111/j.1444-0938.2012.00770.x. Review.

4.

Visual signs and symptoms of multiple system atrophy.

Armstrong RA.

Clin Exp Optom. 2014 Nov;97(6):483-91. doi: 10.1111/cxo.12206. Review.

5.

Diagnostic criteria for multiple system atrophy and progressive supranuclear palsy.

Wenning GK, Colosimo C.

Rev Neurol (Paris). 2010 Oct;166(10):829-33. doi: 10.1016/j.neurol.2010.07.004. Review.

PMID:
20813385
6.

A differential diagnosis of Parkinsonism.

Weiner WJ.

Rev Neurol Dis. 2005 Summer;2(3):124-31. Review.

PMID:
16400311
7.

Visual hallucinations in the differential diagnosis of parkinsonism.

Bertram K, Williams DR.

J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):448-52. doi: 10.1136/jnnp-2011-300980. Review.

8.

Clinical manifestations of Parkinson's disease and parkinsonism.

Hobson DE.

Can J Neurol Sci. 2003 Mar;30 Suppl 1:S2-9. Review.

PMID:
12691471
9.

Visual signs and symptoms of progressive supranuclear palsy.

Armstrong RA.

Clin Exp Optom. 2011 Mar;94(2):150-60. doi: 10.1111/j.1444-0938.2010.00504.x. Review.

10.

Genetic susceptibility variants in parkinsonism.

Soto-Ortolaza AI, Ross OA.

Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S7-11. doi: 10.1016/j.parkreldis.2015.09.011. Review.

11.

[Sleep disorders and parkinsonian syndromes].

Monaca C.

Rev Neurol (Paris). 2008 Dec;164(12 Suppl):F253-62. doi: 10.1016/S0035-3787(08)75126-9. Review. French. No abstract available.

PMID:
19268188
13.

Oculo-visual changes and clinical considerations affecting older patients with dementia.

Armstrong R, Kergoat H.

Ophthalmic Physiol Opt. 2015 Jul;35(4):352-76. doi: 10.1111/opo.12220. Review.

PMID:
26094831
14.

[Contribution of oculomotor examination for the etiological diagnosis of parkinsonian syndromes].

Pierrot-Deseilligny Ch, Rivaud-Péchoux S.

Rev Neurol (Paris). 2003 May;159(5 Pt 2):3S75-81. Review. French.

PMID:
12773891
15.

[Neurophysiology of parkinsonian syndromes].

Defebvre L, Cassim F.

Rev Neurol (Paris). 2003 May;159(5 Pt 2):3S62-74. Review. French.

PMID:
12773890
16.

The role of neuroimaging in the diagnosis of the atypical parkinsonian syndromes in clinical practice.

Dąbrowska M, Schinwelski M, Sitek EJ, Muraszko-Klaudel A, Brockhuis B, Jamrozik Z, Sławek J.

Neurol Neurochir Pol. 2015;49(6):421-31. doi: 10.1016/j.pjnns.2015.10.002. Review.

PMID:
26652877
17.

Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.

Liscic RM, Srulijes K, Gröger A, Maetzler W, Berg D.

Acta Neurol Scand. 2013 May;127(5):362-70. doi: 10.1111/ane.12067. Review.

PMID:
23406296
18.

Neurophysiological characterization of parkinsonian syndromes.

Valls-Solé J.

Neurophysiol Clin. 2000 Dec;30(6):352-67. Review.

PMID:
11191928
19.

[The eye as a window to the pathophysiology in Parkinson's syndromes].

Kassubek J, Danek A, Del Tredici-Braak K, Greenlee MW, Pinkhardt EH.

Nervenarzt. 2013 Aug;84(8):909-17. doi: 10.1007/s00115-013-3754-3. Review. German.

PMID:
23760595
20.

[Dopaminergic treatment and parkinsonian syndromes].

Ghawche F, Durif F.

Rev Neurol (Paris). 2003 May;159(5 Pt 2):3S83-6. Review. French.

PMID:
12773892
Items per page

Supplemental Content

Support Center